Brief: Pharmasimple H1 EBITDA Loss Widens To 3.6 Million Euros

Pharmasimple SA

11/10/2022 17:08

Oct 11 (Reuters) - Pharmasimple SA  ALPHS.PA :
    * H1 EBITDA LOSS EUR 3.6 MILLION VERSUS LOSS OF EUR 1.7
MILLION
YEAR AGO
    * H1 NET LOSS EUR 6.0 MILLION VERSUS LOSS EUR 3.0 MILLION
YEAR AGO
    * CONTINUATION OF THE TRANSFORMATION STRATEGY
    * THE OBJECTIVE OF ACQUIRING AT LEAST 15 PHARMACIES BY 2022
WILL
BE ACHIEVED
    * AS OF JUNE 30, 2022, THE NET DEBT AMOUNTS TO 3.5 MEUR AND
THE
ACTIVE CASH POSITION IS DISPLAYED AT 3.6 MEUR
    * H1 REVENUE EUR 13.6 MILLION VERSUS EUR 15.9 MILLION YEAR
AGO

Source text for Eikon:  urn:newsml:reuters.com:*:nACT76671
Further company coverage:  ALPHS.PA 
 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))